A2 Milk targets China rebound after infant formula sales plunge 60pc

A2 Milk targets China rebound after infant formula sales plunge 60pc

Summary

A2 Milk's annualised revenue from China-label infant formula fell from an estimated NZ$535 million to less than half that level by August, a 60 per cent drop, after global supply chain bottlenecks linked to the US-Iran conflict caused stockouts at maternal and baby stores and domestic e-commerce platforms between April and May, prompting Chinese parents to switch to rival formula brands. The company told investors it has now restored sales to 50 per cent of pre-stockout levels. To rebuild its China distribution channels, A2 Milk is rolling out an aggressive recovery plan aimed at rebuilding consumer loyalty, recruiting new mothers and repairing damaged distributor relationships, while planning to launch two new China-label products to replenish dealer inventories and give bricks-and-mortar retailers a reason to reallocate prime shelf space.

The company has maintained its FY2027 revenue and earnings growth forecasts and is sticking to its target of NZ$2 billion in annual revenue by the end of FY2027, with China sales performance over the coming quarters set to be a key test.

Commentary

A2 Milk's annualised China infant formula revenue has plunged 60 per cent, a decline well above the industry average that underscores the severe impact of global supply chain disruption on businesses dependent on a single market. As a flagship of New Zealand's dairy industry, A2 Milk once carved out a position in China's premium segment through its A2 protein differentiation, but the stockout episode has exposed the fragility of its China-label product distribution network. Of note to New Zealand SME owners, China's infant formula market has entered a phase of stock competition, with a steadily declining birth rate shrinking the overall category, while domestic brands such as Feihe and Yili continue to squeeze foreign brands' share through stable supply chains and channel penetration strategies.

Whether A2 Milk's recovery plan succeeds hinges on its ability to rebuild trust with maternal and baby stores and e-commerce platforms, not merely restore supply. From a competitive standpoint, Chinese regulators' strict enforcement of the formula registration system has raised barriers to entry, requiring foreign brands to invest more resources in local compliance and channel maintenance. For other New Zealand food companies reliant on the China market, A2 Milk's lesson is a warning: supply chain risk in a single market must be hedged through diversified logistics solutions and local inventory buffers.

Moreover, A2 Milk has kept its FY2027 NZ$2 billion revenue target unchanged, implying China sales must rebound strongly in coming quarters, yet Chinese consumers' brand loyalty to imported formula is currently waning and price sensitivity rising, so A2 Milk may need to sacrifice some margin to gain market share. New Zealand SMEs involved in exports to China should closely monitor inventory turnover data and distributor confidence indicators in China's maternal and baby channels, as these leading indicators reflect actual sell-through better than financial statements.

Keywords: A2 Milk, China infant formula, 60 per cent sales decline, supply chain disruption, distribution network rebuild, China-label products, FY2027 target, NZ$2 billion


Photo by holgerheinze0 on Pixabay

Source: Retail News Asia

Disclaimer: This article is compiled from publicly available sources for general information only. The analysis and commentary are editorial opinions. MiDeer Observer does not guarantee the accuracy or completeness of the information provided. Readers should seek independent professional advice before relying on this content, or contact us for more information.

Leave a Reply

Your email address will not be published. Required fields are marked *